Renflexis 100 MG vials
Ended Awarded
- Contract number
- SPE2DB25FSCUY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,527
Award facts
- Contract value 100% obligated
- $13,526.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,526.52 to AmerisourceBergen Drug Corp for the supply of Renflexis 100 mg vials, with an ultimate completion date of August 14, 2025. This is a firm fixed-price delivery order under a non-competitive set-aside arrangement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain.
This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The parent IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and medical commodities across multiple therapeutic domains. This arrangement allows AmerisourceBergen to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through a flexible contract structure aligned with DLA's strategic pharmaceutical procurement objectives.
Quick answers
Who was awarded contract SPE2DB25FSCUY?
SPE2DB25FSCUY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 13, 2025.
How much is contract SPE2DB25FSCUY worth?
The government has obligated $13,527 on SPE2DB25FSCUY.
Is contract SPE2DB25FSCUY an order under another contract?
Yes. SPE2DB25FSCUY is a delivery order under SPE2DB22D2211, an indefinite delivery contract.
Was contract SPE2DB25FSCUY competed?
The extent of competition for SPE2DB25FSCUY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award